Swiss pharma hub Basel frets over population cap threat - Reuters
Swiss pharma hub Basel frets over population cap threat Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"It would mean uncertainty from day one."
— Conradin Cramer , Politician
"Switzerland's position as a leading innovation hub relies on top talent; without this talent, we jeopardize not only research but also the jobs across our entire supply chain."
— Juerg Erismann , Executive
"For companies considering investing in Switzerland and perhaps building new factories or research institutions, this is, of course, poison."
— Stephan Mumenthaler , Executive
Key People
Head of the cantonal government of the city of Basel.
Head of Roche's Basel site.
Director of Swiss pharma and chemicals industry association scienceindustries.
The Swiss People's Party is a major political party in Switzerland known for its rightwing policies.
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOR2R1XzUtSG9VVTU3TFIyTnZMUlV0eUZKMHZIZ080RnA2d2VFVkRfNEZBcGtqbVFuN2FycjBBN083TnRtVjB3TzhieDFzV2Vkbnp4a0c1RW9zSlpZb2dSTGRDSm51aEpNbWFFWE13cU1tT2FSTXJFOWdWQXRXd2lQczEyX2R5RnhVaFp3YWcyTVpKWW9QbWRmenUzZ0ljYVoyQWc?oc=5" target="_blank">Swiss pharma hub Basel frets over population cap threat</a> <font color="#6f6f6f">Reuters</font>
Basel's pharmaceutical industry, including giants Roche and Novartis, expresses concern over a proposed population cap in Switzerland, fearing it could hinder access to skilled labor and impact economic growth.
Executives, including Roche's chairman, express concerns over a proposed population cap in Switzerland, emphasizing the need for international talent to sustain economic growth.
Swiss businesses, including pharmaceutical companies, express concerns over a proposed population cap, fearing it could limit access to skilled labor and strain relations with the European Union.
Similar Stories
Related coverage based on topic and tags
Swiss voters set to reject initiative to tighten neutrality rules - Reuters
Swiss voters set to reject initiative to tighten neutrality rules Reuters
September 27, 2026 at 10:17 AMBioNTech to shutter three sites in Germany as no buyers emerge - Reuters
BioNTech to shutter three sites in Germany as no buyers emerge Reuters
September 28, 2026 at 08:00 PMForeign banks have expressed UBS merger interest, Swiss newspaper reports - Reuters
Foreign banks have expressed UBS merger interest, Swiss newspaper reports Reuters
September 27, 2026 at 08:56 PMSwiss vote on tightening neutrality rules, ending peacetime cooperation with NATO - Reuters
Swiss vote on tightening neutrality rules, ending peacetime cooperation with NATO Reuters
September 27, 2026 at 06:03 AMBayer to invest $2.2 billion in new US pharma site - Reuters
Bayer to invest $2.2 billion in new US pharma site Reuters
October 2, 2026 at 07:19 PMG20 trade chiefs to denounce food trade coercion but not excess factory capacity - Reuters
G20 trade chiefs to denounce food trade coercion but not excess factory capacity Reuters
October 1, 2026 at 11:27 PM